NEW YORK, N.Y.—May 25, 2007
New York’s Hospital for Special Surgery celebrates its 24th annual tribute dinner at the World Financial Center Winter Garden. This event is an opportunity to celebrate advances in the field of musculoskeletal treatment and research and to honor individuals who have embraced the spirit of the hospital and supported its mission.
At this event, Richard S. Fuld, Jr., chairman and CEO of Lehman Brothers, will receive a special honor and renowned hip surgeon Eduardo A. Salvati, M.D., will receive a lifetime achievement award for his contributions to the hospital and the field of orthopedic surgery. His work has encompassed basic, applied, clinical and biomechanical research to refine the complex aspects of total hip replacement. Dr. Salvati has been a driving force at Hospital for Special Surgery for 35 years, dedicating his professional career to the care of thousands of patients and to the education and surgical training of residents and fellows.
The dinner will be hosted by Tony and Emmy Award-winning actress, Bebe Neuwirth.
|When:||Thursday, June 7, 2007
6:30 p.m. – 9 p.m.
Cocktail reception begins at 6:30 p.m.
Dinner begins at 7:30 p.m.
|Where:||The World Financial Center Winter Garden|
|Who:||The following individuals have special roles for the evening’s event:
About HSS | Hospital for Special Surgery
HSS is the world’s leading academic medical center focused on musculoskeletal health. At its core is Hospital for Special Surgery, nationally ranked No. 1 in orthopedics (for the eighth consecutive year) and No. 3 in rheumatology by U.S. News & World Report (2017-2018). Founded in 1863, the Hospital has one of the lowest infection rates in the country, and was the first in New York State to receive Magnet Recognition for Excellence in Nursing Service from the American Nurses Credentialing Center four consecutive times. An affiliate of Weill Cornell Medical College, HSS has a main campus in New York City and facilities in New Jersey, Connecticut and in the Long Island and Westchester County regions of New York State. In 2017 HSS provided care to 135,000 patients from 80 countries, and performed more than 32,000 surgical procedures. In addition to Patient Care, HSS leads the field in research, innovation, and education. The HSS Research Institute comprises 20 laboratories and 300 staff members focused on leading the advancement of musculoskeletal health through prevention of degeneration, tissue repair, and tissue regeneration. The HSS Innovation Institute was formed in 2015 to realize the potential of new drugs, therapeutics and devices; the global standard total knee replacement was developed at HSS in 1969, and in 2017 HSS made 130 invention submissions (more than 2x the submissions in 2015). The HSS Education Institute provides continuing medical curriculum to more than 15,000 subscribing musculoskeletal healthcare professionals in 110 countries. Through HSS Global, the institution is collaborating with medical centers worldwide to advance the quality and value of care, and to make world-class HSS care more accessible to more people.